CD72-semaphorin3A axis: a possible new player in immune regulation
N. Eiza, Z. Vadasz, A. Sabag, O. Kessler, G. Neufeld, Y. Jones
The paper identifies CD72 as a novel sema3A receptor that transduces inhibitory signals in B cells and proposes a modified sema3A as a potential therapeutic for autoimmune diseases.
bioRxiv · Aug 24, 2021 · PreprintImmunology